메뉴 건너뛰기




Volumn 174, Issue 1, 2014, Pages 191-192

Treatment decision making in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: State of the art

Author keywords

Antiarrhythmic drugs; Cardiac transplantation; Implantable cardioverter defibrillator; Management; Radiofrequency catheter ablation; Sudden death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

EID: 84901193911     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.03.180     Document Type: Article
Times cited : (6)

References (10)
  • 1
    • 84875335347 scopus 로고    scopus 로고
    • Arrhythmogenic right ventricular dysplasia
    • H. Calkins Arrhythmogenic right ventricular dysplasia Curr Probl Cardiol 38 3 2013 Mar 103 123
    • (2013) Curr Probl Cardiol , vol.38 , Issue.3 , pp. 103-123
    • Calkins, H.1
  • 2
    • 82955232411 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy
    • W. Smith Guidelines for the diagnosis and management of arrhythmogenic right ventricular cardiomyopathy Heart Lung Circ 20 12 2011 757 760
    • (2011) Heart Lung Circ , vol.20 , Issue.12 , pp. 757-760
    • Smith, W.1
  • 3
    • 33748575897 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology
    • D.P. Zipes, A.J. Camm, and M. Borggrefe et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
    • (2006) Circulation , vol.114
    • Zipes, D.P.1    Camm, A.J.2    Borggrefe, M.3
  • 5
    • 34447636778 scopus 로고    scopus 로고
    • Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy
    • D. Dalal, R. Jain, and H. Tandri et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 50 2007 432 440
    • (2007) J Am Coll Cardiol , vol.50 , pp. 432-440
    • Dalal, D.1    Jain, R.2    Tandri, H.3
  • 6
    • 84863704379 scopus 로고    scopus 로고
    • Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy
    • B. Philips, S. Madhavan, and C. James et al. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Arrhythm Electrophysiol 5 2012 499 505
    • (2012) Circ Arrhythm Electrophysiol , vol.5 , pp. 499-505
    • Philips, B.1    Madhavan, S.2    James, C.3
  • 7
    • 44649192645 scopus 로고    scopus 로고
    • ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology
    • A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation 117 21 2008 e350 e408
    • (2008) Circulation , vol.117 , Issue.21
    • Epstein, A.E.1    Dimarco, J.P.2    Ellenbogen, K.A.3
  • 8
    • 80053048855 scopus 로고    scopus 로고
    • Incidence and predictors of implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy undergoing implantable defibrillator implantation for primary prevention
    • A. Bhonsale, C.A. James, and C. Tichnell et al. Incidence and predictors of implantable cardioverter defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable defibrillator implantation for primary prevention JACC 58 2011 1485 1496
    • (2011) JACC , vol.58 , pp. 1485-1496
    • Bhonsale, A.1    James, C.A.2    Tichnell, C.3
  • 9
    • 9144273930 scopus 로고    scopus 로고
    • Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia
    • D. Corrado, L. Leoni, and M.S. Link et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Circulation 108 25 2003 3084 3091
    • (2003) Circulation , vol.108 , Issue.25 , pp. 3084-3091
    • Corrado, D.1    Leoni, L.2    Link, M.S.3
  • 10
    • 84900575721 scopus 로고    scopus 로고
    • Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy
    • R.M. Inciardi, A. Rotolo, and G. Coppola et al. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy Int J Cardiol 172 3 2014 Apr 1 468 469
    • (2014) Int J Cardiol , vol.172 , Issue.3 , pp. 468-469
    • Inciardi, R.M.1    Rotolo, A.2    Coppola, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.